New Delhi: US pharma giant Johnson and Johnson will soon begin clinical trials of its single-shot Covid-19 vaccine in India, the company told Indian regulators. In a letter to India’s Central Drugs Standard Control Organization (CDSCO), the US-based company said that it would “very shortly to apply for permission to conduct clinical bridging trials in India”. The news has come at a time when India is going through second Covid wave. India is looking to ramp up its vaccine doses amidst high demand due to the second surge of coronavirus in the country, with several states saying they are running out of supplies. In February, the US regulators had issued Emergency Use Authorization for the Covid vaccine developed by J&J’s Janssen Pharmaceutical Companies.